Bevacizumab-induced thrombotic microangiopathy and nephrotic syndrome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Link
http://link.springer.com/article/10.1007/s10157-018-1596-9/fulltext.html
Reference5 articles.
1. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Hass M, Weisstuch J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129–36.
2. Izzedine H, Escudier B, Lhomme C, Pautier P, Rouvier P, Guetin V, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF). Medicine. 2014;93:333–9.
3. Nagata M. Podocyte injury and its consequences. Kidney Int. 2016;89:1221–30.
4. Wu S, Kim C, Baer L, Zhu X. Bevacizumab increases risk for severe proteinuria in cancer patients. J Am Soc Nephrol. 2010;21:1381–9.
5. Yahata M, Nakaya I, Sakuma T, Sato H, Aoki S, Soma J. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature. BMC Res Notes. 2013;6:450.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chronic thrombotic microangiopathy presenting as acute nephrotic syndrome in a patient with renal cancer receiving tyrosine kinase inhibitor therapy;BMJ Case Reports;2024-01
2. A Case of Recurrent Ovarian Cancer with Renal Dysfunction Associated with the Use of Olaparib;SN Comprehensive Clinical Medicine;2023-01-13
3. Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report;Pediatric Hematology Oncology Journal;2022-12
4. Central Nervous System Ischemia Associated with Bevacizumab: An Analysis of the Japanese Adverse Drug Event Report Database;Biological and Pharmaceutical Bulletin;2022-12-01
5. A case of recurrent ovarian cancer with renal dysfunction associated with the use of olaparib;2022-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3